Aug 13, 2026 02:21PM
Jul 27, 2026 03:20PM
Jun 5, 2026 10:00AM
Apr 8, 2026 12:14PM
Apr 1, 2026 11:50AM
Jan 13, 2026 09:00AM
Oct 30, 2025 09:01AM DIAGNOS appoints Philippe Couillard as board chairman
Oct 30, 2025 09:00AM
Oct 8, 2025 09:00AM
Jul 16, 2025 09:00AM
Jun 4, 2025 06:30AM
Mar 31, 2025 09:00AM
Mar 12, 2025 09:15AM
Feb 25, 2025 09:05AM DIAGNOS to File for FDA Pre-Market Authorization of Its AI-Powered CARA SYSTEM and Engages Ora as Regulatory Specialist
Aug 20, 2024 09:45AM
Apr 16, 2024 11:08AM
May 17, 2023 12:49PM
Feb 28, 2023 09:00AM
Feb 14, 2023 10:36AM
Feb 10, 2023 03:56PM
Jan 31, 2023 10:04AM DIAGNOS Gets the Green Light for the Use of its Diabetic Retinopathy Screening Technology in Quebec Hospitals
Oct 27, 2022 11:29AM
Sep 1, 2022 09:30AM
Aug 18, 2022 12:26PM
Jul 27, 2022 09:00AM
Jun 23, 2022 09:00AM
Jun 7, 2022 11:44AM
May 26, 2022 09:58AM DIAGNOS and the CHUM are launching the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening
May 10, 2022 10:32AM
Apr 26, 2022 09:00AM
Mar 28, 2022 04:15PM
Mar 15, 2022 02:00PM
Mar 1, 2022 12:54PM
Feb 10, 2022 10:14AM
Dec 15, 2021 09:00AM DIAGNOS will be Attending in San Francisco during the J.P. Morgan Health Care Conference Week to be held from January 10th to 13th, 2022
Nov 23, 2021 09:00AM
Oct 28, 2021 09:00AM
Sep 24, 2021 09:00AM
Sep 16, 2021 09:00AM
Sep 14, 2021 09:00AM
Sep 10, 2021 01:34PM
Sep 2, 2021 09:00AM DIAGNOS Announces a Three-Year Contract Renewal with Optina Diagnostics Providing a Telemedicine Platform to Support their Early Detection of Alzheimer’s Disease Test
Aug 17, 2021 03:30PM
Aug 16, 2021 09:00AM
Jul 28, 2021 09:05AM
Jul 22, 2021 09:05AM
Jul 20, 2021 10:05AM
Jun 15, 2021 11:20AM
Jun 9, 2021 08:00AM IRIS, a New Look Vision Group Inc. company, teams up with DIAGNOS in a multi-year agreement to implement Artificial Intelligence technology with support from the INVEST-AI Program

330,120 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All